Lilly to Acquire Centessa Pharmaceuticals for $1.15B | Drug Development News
Eli Lilly (NYSE: LLY) announced today, March 31, 2026, a definitive agreement to acquire **Centessa Pharmaceuticals (NASDAQ: CNTA)** for $6.3 billion in cash. The deal targets Centessa’s lead drug candidate, ... Read More